Abstract
Mitochondria are essential organelles in eukaryotic cells and are responsible for regulating energy metabolism, ROS production, and cell survival. Recently, various cellular pathogeneses, including tumorigenesis and metastasis, have been reported to be associated with mitochondrial homeostasis. Consequently, exploiting the correlation between dysfunctional mitochondria and tumor progression has been implicated in the understanding of tumorigenesis, tumor metastasis, and chemoresistance, along with novel strategies to develop cancer therapeutics. To comprehensively understand the role of the mitochondria in cancer metastasis, it is necessary to resolve thousands of mitochondrial proteins and their post-translational modifications with high-throughput global assessments. We introduce mitochondrial proteomic strategies in this review and a discussion on their recent findings related to cancer metastasis. Additionally, the mitochondrial respiratory chain is believed to be a major site for ROS production, and elevated ROS is likely a key source to trigger dysfunctional mitochondria and impaired mitochondrial metabolism that subsequently contribute to the development of cancer progression. Equipment-based metabolomic analysis now allows the monitoring of disease progression and diagnosis. These newly emerging techniques, including proteomics, redox-proteomics, and metabolomics, are described in this review.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Andreyev AY et al (2005) Mitochondrial metabolism of reactive oxygen species. Biochemistry (Mosc) 70:200–214
Blagoev B et al (2003) A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 21:315–318
Boveris A, Chance B (1973) The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134:707–716
Calcinotto A et al. (2012) Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes. Cancer Res 72:2746–2756
Calvo SE, Mootha VK (2010) The mitochondrial proteome and human disease. Annu Rev Genomics Hum Genet 11:25–44
Chan HL et al (2005) Proteomic analysis of redox- and ErbB2-dependent changes in mammary luminal epithelial cells using cysteine- and lysine-labelling two-dimensional difference gel electrophoresis. Proteomics 5:2908–2926
Chan HL et al (2006) Proteomic analysis of UVC irradiation-induced damage of plasma proteins: serum amyloid P component as a major target of photolysis. FEBS Lett 580:3229–3236
Chan HL et al (2012) Proteomic analysis of redox-dependent changes using cysteine-labeling 2D DIGE. Methods Mol Biol 854:113–128
Chen EI et al (2007) Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res 67:1472–1486
Chen YW et al (2011) Mitochondrial proteomics analysis of tumorigenic and metastatic breast cancer markers. Funct Integr Genomics 11:225–239
Chou HC et al (2012) Proteomic and redox-proteomic analysis of berberine-induced cytotoxicity in breast cancer cells. J Proteomics 75:3158–3176
Da Cruz S et al (2005) Building the mitochondrial proteome. Exp Rev Proteomics 2:541–551
DeSouza L et al (2005) Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J Proteome Res 4:377–386
Dunkley TP et al (2004) The use of isotope-coded affinity tags (ICAT) to study organelle proteomes in Arabidopsis thaliana. Biochem Soc Trans 32:520–523
Evans C et al. (2012) An insight into iTRAQ: where do we stand now? Anal Bioanal Chem. doi:10.1007/s00216-012-5918-6
Fenn JB et al (1989) Electrospray ionization for mass spectrometry of large biomolecules. Science 246:64–71
Fulda S et al (2010) Targeting mitochondria for cancer therapy. Nat Rev Drug Discov 9:447–464
Gogvadze V et al (2008) Mitochondria in cancer cells: what is so special about them? Trends Cell Biol 18:165–173
Gogvadze V et al (2009) Mitochondria as targets for cancer chemotherapy. Semin Cancer Biol 19:57–66
Goh J et al (2011) Mitochondrial targeted catalase suppresses invasive breast cancer in mice. BMC Cancer 11:191
Goswami PC (2009) Mutant mitochondria and cancer cell metastasis: quest for a mechanism. Cancer Biol Ther 8:1386–1388
Green DR (1998) Apoptotic pathways: the roads to ruin. Cell 94:695–698
Gygi SP et al (1999) Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 17:994–999
Han J et al (2008) Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry. Metabolomics 4:128–140
Herrmann PC, Herrmann EC (2012) Mitochondrial proteome: toward the detection and profiling of disease associated alterations. Methods Mol Biol 823:265–277
Herrmann PC et al (2003) Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. Proteomics 3:1801–1810
Karas M, Hillenkamp F (1988) Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem 60:2299–2301
Karas M et al (2000) Ionization in matrix-assisted laser desorption/ionization: singly charged molecular ions are the lucky survivors. J Mass Spectrom 35:1–12
King A et al (2006) Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer. Oncogene 25:4675–4682
Koulman A et al (2009) High-resolution extracted ion chromatography, a new tool for metabolomics and lipidomics using a second-generation orbitrap mass spectrometer. Rapid Commun Mass Spectrom 23:1411–1418
Kulawiec M et al (2009) Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Ther 8:1378–1385
Lai TC et al (2010) Secretomic and Proteomic Analysis of Potential Breast Cancer Markers by Two-Dimensional Differential Gel Electrophoresis. J Proteome Res 9:1302–1322
Levine AJ, Puzio-Kuter AM (2010) The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330:1340–1344
Li K et al (2000) Cytochrome c deficiency causes embryonic lethality and attenuates stress-induced apoptosis. Cell 101:389–399
Mehlen P, Puisieux A (2006) Metastasis: a question of life or death. Nat Rev Cancer 6:449–458
Nagrath D et al (2011) Metabolomics for mitochondrial and cancer studies. Biochim Biophys Acta 1807:650–663
Paweletz CP et al (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1989
Pelicano H et al (2006) Glycolysis inhibition for anticancer treatment. Oncogene 25:4633–4646
Pimienta G et al (2009) SILAC for global phosphoproteomic analysis. Methods Mol Biol 527:107–116, x
Robey RB, Hay N (2006) Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25:4683–4696
Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30:1191–1212
Seifert EL et al (2010) Long-chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondria. PLoS One 5:e9834
Shaham O et al (2010) A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells. Proc Natl Acad Sci U S A 107:1571–1575
Simonnet H et al (2002) Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis 23:759–768
Timms JF, Cramer R (2008) Difference gel electrophoresis. Proteomics 8:4886–4897
Tu YF et al (2011) Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties. Biochim Biophys Acta 1807:1125–1132
Verma M et al (2003) Proteomic analysis of cancer-cell mitochondria. Nat Rev Cancer 3:789–795
Wang GQ et al (2001) A role for mitochondrial Bak in apoptotic response to anticancer drugs. J Biol Chem 276:34307–34317
Warburg OU (1926) Translated: The metabolism of tumors. London: Arnold Constable. Springer, Berlin
Weckwerth W (2010) Metabolomics: an integral technique in systems biology. Bioanalysis 2:829–836
Weigelt B et al (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602
Whitehouse CM et al (1985) Electrospray interface for liquid chromatographs and mass spectrometers. Anal Chem 57:675–679
Wu CL et al. (2012) Proteomic analysis of UVB-induced protein expression- and redox-dependent changes in skin fibroblasts using lysine- and cysteine-labeling two-dimensional difference gel electrophoresis. J Proteomics 75:1991–2014
Zhang L et al (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992
Zhang A et al (2012) Modern analytical techniques in metabolomics analysis. Analyst 137:293–300
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chou, HC., Chan, HL. Targeting proteomics to investigate metastasis-associated mitochondrial proteins. J Bioenerg Biomembr 44, 629–634 (2012). https://doi.org/10.1007/s10863-012-9466-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10863-012-9466-8